FDA opposes Treasury halting public sector pension scheme valuations
FDA Assistant General Secretary Lucille Thirlby has publicly spoken against the partial pause of public sector pension scheme valuations.
On Wednesday 30 January, Chief Secretary to the Treasury Liz Truss announced that the Government was temporarily stopping “one element of the valuations of public service pensions.”
In a public statement, Thirlby said: “The FDA opposes the Treasury halting any element of the public sector scheme valuations. Would the Treasury be delaying if the cost cap meant an increase in subscriptions?
“The Civil Service Pension Scheme valuation identified a breach of the cost cap floor, meaning it has operated cheaper than expected. The members of this scheme should be reaping the rewards of this.
“For years, civil servants have suffered from real term pay cuts. Now improvements to their pension benefits aren’t being realised. This is just adding insult to injury.
“The Government created a set of agreed rules to last for 25 years – now it is trying to back out. By halting this process, Civil Service Pension Scheme members will be unable to benefit from lower contributions or improved benefits for an unknown length of time.
“The FDA will continue to fight for its members access to affordable and sustainable pensions. The Treasury approach, yet again, seeks to crack a nut with a sledgehammer.”
Thirlby’s comments were reported in a Civil Service World article about this valuations pause.
Related News
-
Government’s plans for civil service reform “lack substance”, says FDA
The FDA has criticised the government’s rhetoric surrounding the announcement of a series of civil service reforms – on performance-based pay, fast track exits for underperformers, and performance management – by Chancellor of the Duchy of Lancaster Pat McFadden.
-
9% pay rise for NI civil servants ‘genuine attempt to tackle pay erosion’, says FDA
The FDA is recommending to members to accept the Northern Ireland civil service pay offer for 2024/25, which represents a 9% increase over a 20-month period.
-
FDA calls for widespread reform across the civil service in New Year message to government
The FDA has shared its annual New Year message to the government, in which FDA Assistant General Secretary Lauren Crowley outlines the need for significant reform across the civil service.